The frequency of cytomegalovirus infection detecting of patients with lung diseases Source: Eur Respir J 2006; 28: Suppl. 50, 153s Year: 2006
Frequency, severity and risk factors of drug-induced liver injury during treatment of new tuberculosis patients Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012
The role of respiratory viruses in etiological structure of exacerbation of chronic and recurrent lung diseases in children Source: Eur Respir J 2007; 30: Suppl. 51, 391s Year: 2007
Worse lung cancer outcome in patients with lower respiratory tract infection confirmed at the time of diagnosis Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019
Eosinopenia in COPD patients with severe acute respiratory virus 2 (Sars-CoV-2) infection as a potential fatal outcome predictor Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021
Influence of lung infection on the course and outcome in patients with stroke Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012
How could we objectively measure lung disease severity in children with severe combined immunodeficiency? Source: Annual Congress 2005 - New insights in respiratory infections in children Year: 2005
EBV and CMV as possible pathogens in patients presenting with interstitial lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 154s Year: 2006
CT quantification of lung lesions as a prognostic factor for severe lung damage in COVID-19 patients Source: Virtual Congress 2021 – COVID - 19 Year: 2021
The role of cytomegalovirus infection in the course of the lung diseases in children Source: Eur Respir J 2005; 26: Suppl. 49, 643s Year: 2005
Ultrasound diaphragm activity as a marker of clinical status and prognosis in acute exacerbations of COPD Source: Virtual Congress 2021 – New insights into the pathophysiology and prognosis of COPD Year: 2021
Clinically relevant early functional and diagnostic markers of lung disease in the paediatric intensive care unit Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=142 Year: 2006
HRCT features do not predict the clinical course in children with protracted bacterial bronchitis Source: Annual Congress 2012 - Paediatric bronchology Year: 2012
Age-related pattern of childhood lung infection and its complications Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=189 Year: 2002
Diffusion ability of the lungs in the assessment of respiratory function in patients who have undergone the new coronavirus infection (COVID-19) Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021
Predictors of major serious manifestations in the terminal stage of lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005
Sporadic coronavirus and human metapneumovirus lower respiratory tract infection in adults: comparison of chest CT findings and correlation with clinical outcomes Source: Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era Year: 2020
Studying lung inflammatory biomarkers using non-invasive methods in patients with community acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002
The use of non-invasive inflammatory markers to predict presence, severity and stability of cystic fibrosis lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 327s Year: 2006
A HRCT score to differentiate between structural and interstitial lung disease in children with common variable immunodeficiency (CVID) Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors Year: 2010